Medical Design & Outsourcing

Selecting the right adhesive for medical wearables is crucial to ensuring long-term performance. Avery Dennison Medical's 28-day study of MED 5744 and MED 3046 adhesives demonstrated their effectiveness in real-world conditions, showcasing both reliability and comfort. This underscores the importance of wear studies to validate adhesive performance, as skin’s dynamic nature can vary across users. Learn more about how adhesive testing ensures wearable success: https://lnkd.in/eDEMNDyj #MedicalDevice #Wearables #MedicalAdhesives #MedTech

What's cooler than PFA? Nanosecond PFA — at least that's the hopes of Pulse Biosciences, Inc., the developer of a nsPFA platform for treating AFib and benign thyroid nodules. “PFA is unique, PFA is disruptive, and nsPFA looks like a shining star within that field,” Pulse Biosciences CEO Paul LaViolette told me in an interview for Medical Design & Outsourcing. He and co-founder and Chief Technology Officer Darrin Uecker discussed their technology and what's next for Pulse Biosciences, which has a big year ahead of it. I'll have more from this interview in the weeks ahead; for now, I've linked to the first post in the comments below.

#Artificialintelligence has become so ubiquitous in #medtech product development that it's hard to find a new product announcement that doesn't include some kind of mention of #AI. So it's exciting that Infor is hosting a #DeviceTalksBoston panel that will include experts from NVIDIA, SoftAcuity Inc, and the Orlando VA Medical Center. They'll discuss how they're working together to enable smarter, faster, and more connected #healthcare. I'll include a registration link in the comments. DeviceTalks Tom Salemi

Don’t miss your chance to enter the 2025 R&D 100 Awards! 🏆 Submit your product or process for the chance to be recognized and earn a spot among top innovators. Enter before the early-bird deadline on 5/2! 📆 https://lnkd.in/enkp-i3N #RD100 #MedicalDevices | R&D - Research & Development World

Össur has moved up five spots on the 2024 Medtech Big 100 list, ranking 76th. Over the decades, Össur’s bracing, support and prosthetics products have expanded to include the Unloader One, a dynamic brace to relieve the pain of knee osteoarthritis, and the Power Knee, the world's first motor-powered prosthetic knee. Learn more about what makes Össur one of the world's top medical device companies — along with the rest of our Medtech Big 100 — here: https://lnkd.in/eBh_DBmi #MedtechBig100 #Fiscal #MedicalDevice #Medtech #Prosthetics

Cordis ranked 75th on our 2024 Medtech Big 100 list! Founded in 1957 and independent once again since its sale to private equity investors in 2021, Cordis develops and manufactures medical devices for diagnostics and interventional procedures to treat coronary and peripheral vascular diseases. Learn more about what makes Cordis one of the world's top medical device companies — along with the rest of our Medtech Big 100 — here: https://lnkd.in/e4qHnHRb #MedtechBig100 #Fiscal #MedicalDevice #Medtech

Today's medtech pay analysis looks at Edwards Lifesciences, which reported $14.6 million in total compensation to CEO Bernard Zovighian in his first full year leading the structural heart device developer and manufacturer since the retirement of longtime leader Mike Mussallem. Edwards also reported a big increase in compensation paid to its median employee. I've got more details at the Medical Design & Outsourcing link in the comments below.

Count Boston Scientific among the #medtech #meddevice companies who continue to publicly stress the importance of #sustainability. On top of it simply being the right thing to do to keep our planet livable, there are also many good business arguments for it. We'll have Kathryn Unger and other top Boston Scientific officials discussing sustainability in just a few weeks at #DeviceTalksBoston, April 30–May 1. (I'll include a registration link in the comments.) Tom Salemi

With European sales and a recent fundraise, Cardiac Dimensions has the fuel it needs to finish the pivotal trial for FDA approval of its minimally invasive Carillon Mitral Contour System for mitral regurgitation. Rick Wypych has been leading the team for more than two decades. We recently discussed their development of the implant and delivery catheter, how the system treats MR, and how they make that nitinol and titanium implant in-house. “We never would have been able to do what we can without nitinol. … The catheter technology coupled with the nitinol metal technology are the two things that really drive the device,” he said. I've got a link to the latest Medical Design & Outsourcing interview in the comments below.

For over 40 years, Altech Corporation has been an established USA supplier of components and devices used in industrial control, instrumentation and automation. It is an ISO 9001:2000 certified manufacturer and distributor of electrical, electronic and electromechanical components. Consider voting for AccuPath in the Electronic Components category of this year's Leadership in MedTech: https://lnkd.in/ePx_Ez8s